-+ 0.00%
-+ 0.00%
-+ 0.00%

ARROWHEAD PHARMACEUTICALS - YOSEMITE PHASE 3 STUDY COMPLETION ANTICIPATED IN MID-2027

Reuters·07/27/2026 11:30:00

Please log in to view news